Related Experiment Video
Updated: Sep 14, 2025

06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.7K
Wearable biosensors for autoimmune disorders.
1School of Biotechnology and Bioengineering, Institute of Advanced Research, Gandhinagar, Gujarat, India.
Progress in Molecular Biology and Translational Science
|July 19, 2025
Summary
Wearable biosensors offer continuous monitoring for autoimmune diseases, tracking biomarkers like cytokines. This technology enables personalized, real-time patient management and improved treatment efficacy for conditions such as rheumatoid arthritis and lupus.
Area of Science:
- Biomedical Engineering
- Immunology
- Wearable Technology
Background:
- Autoimmune disorders affect millions globally, characterized by complex immune attacks and dynamic disease progression.
- Conventional diagnostic and monitoring methods struggle to capture the fluctuating nature of autoimmune diseases and treatment responses.
- There is a critical need for advanced monitoring solutions to manage autoimmune conditions effectively.
Purpose of the Study:
- To review the role of wearable biosensors (WBS) in managing autoimmune diseases.
- To discuss relevant biomarkers and recent technological advancements in biosensor development.
- To explore future prospects including AI, big data, and omics integration for personalized autoimmune disease management.
Main Methods:
- Review of pathophysiology underlying WBS in autoimmune disease management.
- Analysis of relevant biomarkers (cytokines, autoantibodies, acute phase proteins).
- Examination of recent advances in biosensor technology, addressing sensitivity, specificity, stability, and biocompatibility.
Main Results:
- Wearable biosensors enable continuous, minimally invasive monitoring of key biomarkers for autoimmune diseases.
- Recent advances show promise in improving sensor performance and addressing critical issues like sensitivity and stability.
- Future integration with big data analytics, AI, and omics holds potential for predictive modeling and personalized care.
Conclusions:
- Wearable biosensors represent a transformational approach to monitoring autoimmune diseases.
- Addressing technological challenges is crucial for widespread clinical adoption.
- Future innovations promise personalized, data-driven, real-time management of autoimmune conditions.

